FDA clarifies the comment period regarding behind-the-counter availability of some nonprescription drugs continues through Dec. 17, according to a Nov. 27 Federal Register notice.

The agency says it incorrectly listed the closing date for the comment period on BTC availability as Nov. 28 in an Oct. 4 notice. That notice announced the Nov. 14 public meeting the agency conducted in Washihngton to obtain comments from stakeholders in the drug, pharmacy and health care industries on BTC statuts for some drugs.

The docket for BTC comments will remain open until Dec. 17, which will be 30 days after the meeting, FDA says.

thetansheet.com